Sam Schini is currently a Senior Analyst in Investments at Roivant Sciences, having previously held the position of Analyst in the same department. They gained experience as an Undergraduate Student Researcher at the University of Wisconsin-Madison, where they contributed to projects in quantitative MRI and pancreatic beta cell biology. Sam completed a Summer Research Analyst position at Aquilo Capital Management, focusing on diligence workstreams for biotech investments, and served as an MS&T Intern at Merck. They are presently pursuing a Master of Science in Biomedical Engineering at the University of Wisconsin-Madison while also majoring in Biomedical Engineering and Neurobiology.
This person is not in any teams
This person is not in any offices